Digital Therapeutics Market to be Worth $42.98 Billion by 2030
|
|
|
|
Download Sample
Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5427
According
to this latest publication from Meticulous Research®,
the global digital therapeutics market is projected to reach $42.98 billion
by 2030 at a CAGR of 31.1%. The growth of this market is mainly attributed to
the increasing need to reduce healthcare costs, the rising prevalence of
chronic diseases, the high adoption of digital healthcare, and the increasing
focus on preventive healthcare. Moreover, emerging economies and expanding
pipelines for digital therapeutic solutions for various therapy areas offer
significant opportunities for the growth of this market.
Key Players
The
key players operating in the global digital therapeutics market are Noom,
Inc. (U.S.), 2Morrow Inc. (U.S.), GAIA AG (Germany), ResMed Inc. (U.S.),
Canary Health (U.S.), Welldoc, Inc. (U.S.), DarioHealth Corp. (U.S.), Akili,
Inc. (U.S.), Biofourmis Inc. (U.S.), BigHealth (U.S.), Teladoc Health, Inc.
(U.S.), Limbix Health, Inc. (U.S.), Kaia Health Software Inc. (Germany),
Glooko, Inc. (U.S.), and Virta Health Corp. (U.S.).
Digital Therapeutics Market: Future Outlook
The
global digital therapeutics market is segmented by Type (Disease Management
and Treatment DTx and Disease Prevention DTx), Applications (Mental Health,
Diabetes, Cardiovascular Diseases, Gastrointestinal Disorders, Neurology,
Rehabilitation & patient care, Respiratory Disorders, Oncology, Addiction
Management, Sleep Disorders, Smoking Cessation, and Other Applications), End
User (Providers, Individual Consumers, Employers, Payers, and Other End
Users), and Geography. The study also evaluates industry competitors and
analyzes their market share at global and regional levels.
Based on type, in
2023, the disease management and treatment DTx segment is expected to account
for the largest share of the digital therapeutics market. The large market
share of this segment is attributed to the availability of cost-effective
mHealth platforms, the increasing need to control healthcare costs, high
investments in digital health, and strategic collaborations among
stakeholders to launch disease treatment and management of digital
therapeutic platforms.
Based on application, the digital therapeutics market is segmented into
mental health, diabetes, cardiovascular diseases, gastrointestinal disorders,
neurology, rehabilitation and patient care, oncology, respiratory disorders,
addiction management, sleep disorders, smoking cessation, and other
applications. In 2023, the mental health segment is expected to account for
the largest share of the digital therapeutics market due to the increasing
prevalence of mental issues, such as stress, anxiety, and depression.
Additionally, loss in productivity by mental health issues and the need for
cost-effective solutions for stress and depression management are
contributing to the large market share of this segment.
speak to analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5427
Based on end user, the individual consumers segment is expected to grow at
the highest CAGR during the forecast period. The highest CAGR of this segment
is attributed to the increasing awareness and approvals of digital
therapeutic solutions, the high adoption of mHealth platforms, and the trend
of preventive healthcare among patients.
Geographic Review
This
research report analyzes major geographies and provides a comprehensive
analysis of North America (U.S. and Canada), Europe (Germany, France, U.K.,
Italy, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, and
the Rest of Asia-Pacific), Latin America (Brazil, Mexico, and the Rest of
Latin America), and the Middle East & Africa. In 2023, North America is
expected to account for the largest share of the digital therapeutics market.
The large share of this market is attributed to the increased usage of
digital health products, the increasing incidence of chronic diseases, and
government initiatives to support digital healthcare.
Quick buy: https://www.meticulousresearch.com/Checkout/41755794
Key questions answered in the report-
· Which are
the high-growth market segments in terms of type, application, end user, and
regions/countries?
· What was
the historical market for digital therapeutics across the globe?
· What are
the market forecasts and estimates for the period 2023–2030?
· What are
the major drivers, restraints, challenges, opportunities, and trends in the
global digital therapeutics market?
· Who are
the major players in the global digital therapeutics market?
· How is
the competitive landscape, and who are the market leaders in the global
digital therapeutics market?
· What are
the recent developments in the digital therapeutics market?
· What are
the different strategies adopted by the major players in the digital
therapeutics market?
· What are
the geographical trends and high-growth regions/countries?
Contact
Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment